Antidepressants with anti-inflammatory properties may be useful in long COVID depression
Caroline Fenton, Arnold Lee
Topics & Concepts
Coronavirus disease 2019 (COVID-19)AntidepressantDepression (economics)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PharmacyDrug repositioningPandemicPharmacologyPsychiatryInternal medicineDrugVirologyAnxietyDiseaseEconomicsOutbreakInfectious disease (medical specialty)MacroeconomicsFamily medicineLong-Term Effects of COVID-19Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms